Intracellular skeletal muscle glucose metabolism is differentially altered by dexamethasone treatment of normoglycemic relatives of type 2 diabetic patients

Metabolism: Clinical and Experimental

Volumn 48, Issue 9, 1999, Pages 1128-1135

  Henriksen, J E ^a   Alford, F ^b   Vaag, A ^b   Handberg, A ^b   Beck Nielsen, H ^b  

^a ODENSE UNIVERSITY HOSPITAL   (Denmark)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

DEXAMETHASONE; GLUCOSE; GLUCOSE 6 PHOSPHATE; GLYCOGEN; GLYCOGEN SYNTHASE; LACTIC ACID;

ADULT; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; GLUCOSE METABOLISM; GLUCOSE OXIDATION; HUMAN; INSULIN RESISTANCE; LIPID OXIDATION; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; PRIORITY JOURNAL; RELATIVE; SKELETAL MUSCLE;

EID: 0032822890     PISSN: 00260495     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0026-0495(99)90126-9     Document Type: Article

References (47)

1. Kobberling J, Tillil H: Empirical risk figures for first degree relatives of non-insulin dependent diabetics, in Kobberling J, Tattersall R (eds): The Genetics of Diabetes Mellitus. London, UK, Academic, 1982, pp 202-209
2. Vaag A, Henriksen JE, Beck-Nielsen H: Decreased insulin activation of glycogen synthase in skeletal muscles in young nonobese caucasian first-degree relatives of patients with non-insulin-dependent diabetes mellitus. J Clin Invest 89:782-788, 1992
3. Henriksen JE. Alford F, Handberg A, et al: Increased glucose effectiveness in normoglycemic but insulin-resistant relatives of patients with non-insulin-dependent diabetes mellitus. A novel compensatory mechanism. J Clin Invest 94:1196-1204, 1994
4. McMahon M, Gerich J, Rizza R: Effects of glucocorticoids on carbohydrate metabolism. Diabetes Metab Rev 4:17-30, 1988
5. Tappy L. Randin D, Vollenweider P, et al: Mechanisms of dexamethasone-induced insulin resistance in healthy humans. J Clin Endocrinol Metab 79:1063-1069, 1994
6. Ekstrand A, Schalin Jantti C, Lofman M, et al: The effect of (steroid) immunosuppression on skeletal muscle glycogen metabolism in patients after kidney transplantation. Transplantation 61:889-893, 1996
7. Matsumoto K, Yamasaki H, Akazawa S, et al: High-dose but not low-dose dexamethasone impairs glucose tolerance by inducing compensatory failure of pancreatic beta-cells in normal men. J Clin Endocrinol Metab 81:2621-2626, 1996
8. Henriksen JE, Alford F, Ward GM, et al: Risk and mechanism of dexamethasone-induced deterioration of glucose tolerance in non-diabetic first-degree relatives of NIDDM patients. Diabetologia 40:1439-1449, 1997
9. Schalin Jantti C, Harkonen M, Groop LC: Impaired activation of glycogen synthase in people at increased risk for developing NIDDM. Diabetes 41:598-604, 1992
10. Rothman DL, Magnusson I, Cline G, et al: Decreased muscle glucose transport/phosphorylation is an early defect in the pathogenesis of non-insulin-dependent diabetes mellitus. Proc Natl Acad Sci USA 92:983-987, 1995
11. Perseghin G, Price TB, Petersen KG, et al: Increased glucose transport-phosphorylation and muscle glycogen synthesis after exercise training in insulin-resistant subjects. N Engl J Med 335:1357-1362, 1996
12. Henriksen JE, Alford F, Handberg A, et al: Glucose processing during the intravenous glucose tolerance test. Metabolism 45:598-605, 1996
13. Lusk G: Animal calorimetry. Analysis of the oxidation of mixtures of carbohydrate and fat. J Biol Chem 59:41-42, 1924
14. Frayn KN: Calculation of substrate oxidation rates in vivo from gaseous exchange. A Appl Physiol 55:628-634, 1983
15. Ferrannini E: The theoretical bases of indirect calorimetry: A review. Metabolism 37:287-301, 1988
16. Lowry OH, Passonneau JV: A Flexible System of Enzymatic Analysis. New York, NY, Academic, 1972
17. Christopher MJ, Sleeman MW, Alford FP, et al: Contrasting action of short- and long-term adrenaline infusion on dog skeletal muscle glucose metabolism. Diabetologia 35:399-405, 1992
18. Sjogaard G, Adams RP, Saltin B: Water and ion shifts in skeletal muscle of humans with intense dynamic knee extension. Am J Physiol 248:R190-R196, 1985
19. Sjogaard G. Saltin B: Extra- and intracellular water spaces in muscles of man at rest and with dynamic exercise. Am J Physiol 243:R271-R280, 1982
20. Damsbo P, Vaag A, Hother-Nielsen O, et al: Reduced glycogen synthase activity in skeletal muscle from obese patients with and without type 2(non-insulin-dependent) diabetes mellitus. Diabetologia 34:239-245, 1991
21. Lowry OH, Rosenbrough NJ. Farr AL, et al: Protein measurements with Folin phenol reagent. J Biol Chem 193:265-272, 1951
22. Handberg A, Vaag A, Damsbo P, et al: Expression of insulin regulatable glucose transporters in skeletal muscle from type 2 (non-insulin-dependent) diabetic patients. Diabetologia 33:625-627, 1990
23. Tappy L, Owen OE, Boden G: Effect of hyperinsulinemia on urea pool size and substrate oxidation rates. Diabetes 37:1212-1216, 1988
24. Rizza RA, Mandarino LJ, Gerich JE: Cortisol-induced insulin resistance in man: Impaired suppression of glucose production and stimulation of glucose utilization due to a postreceptor defect of insulin action. J Clin Endocrinol Metab 54:131-138, 1982
25. Price TB, Perseghin G, Duleba A, et al: NMR studies of muscle glycogen synthesis in insulin-resistant offspring of parents with non-insulin-dependent diabetes mellitus immediately after glycogen-depleting exercise. Proc Natl Acad Sci USA 93:5329-5334, 1996
26. Eriksson J, Franssila Kallunki A, Ekstrand A, et al: Early metabolic defects in persons at increased risk for non-insulin-dependent diabetes mellitus. N Engl J Med 321:337-343, 1989
27. Sugden MC, Holness MJ, Fryer LG: Differential regulation of glycogen synthase by insulin and glucose in vivo in skeletal muscles of the rat. Am J Physiol 273:E479-E487, 1997
28. Rossetti L, Giaccari A: Relative contribution of glycogen synthesis and glycolysis to insulin-mediated glucose uptake. A dose-response euglycemic clamp study in normal and diabetic rats. J Clin Invest 85:1785-1792, 1990
29. Vaag A, Damsbo P, Hother-Nielsen O, et al: Hyperglycaemia compensates for the defects in insulin-mediated glucose metabolism and in the activation of glycogen synthase in the skeletal muscle of patients with type 2 (non-insulin-dependent) diabetes mellitus. Diabetologia 35:80-88, 1992
30. Castillo CE, Katz A, Spencer MK, et al: Fasting inhibits insulin-mediated glycolysis and anaplerosis in human skeletal muscle. Am J Physiol 261:E598-E605, 1991
31. Hargreaves M, Kiens B, Richter EA: Effect of increased plasma free fatty acid concentrations on muscle metabolism in exercising men. J Appl Physiol 70:194-201, 1991
32. Vogt C, Petrides AS: Stimulation of muscle glucose disposal by insulin in humans is a function of the preexisting plasma insulin level. Am J Physiol 268:E1031-E1038, 1995
33. Bak JF, Moller N, Schmitz O, et al: Effects of hyperinsulinemia and hyperglycemia on insulin receptor function and glycogen synthase activation in skeletal muscle of normal man. Metabolism 40:830-835, 1991
34. 31P nuclear magnetic resonance measurements of muscle glucose-6-phosphate. Evidence for reduced insulin-dependent muscle glucose transport or phosphorylation activity in non-insulin-dependent diabetes mellitus. J Clin Invest 89:1069-1075, 1992
35. Rossetti L, Hu M: Skeletal muscle glycogenolysis is more sensitive to insulin than is glucose transport/phosphorylation. Relation to the insulin-mediated inhibition of hepatic glucose production. J Clin Invest 92:2963-2974, 1993
36. Ortmeyer HK, Bodkin NL, Hansen BC. Relationship of skeletal muscle glucose-6-phosphate to glucose disposal rate and glycogen synthase activity in insulin-resistant and non-insulin-dependent diabetic rhesus monkeys. Diabetologia 37:127-133, 1994
37. Yki-Jarvinen H, Mott D, Young AA, et al. Regulation of glycogen synthase and phosphorylase activities by glucose and insulin in human skeletal muscle. J Clin Invest 80:95-100, 1987
38. Rossetti L, Lee YT, Ruiz J, et al: Quantitation of glycolysis and skeletal muscle glycogen synthesis in humans. Am J Physiol 265:E761-E769, 1993
39. Castilo C, Bogardus C, Bergman R, et al: Interstitial insulin concentrations determine glucose uptake rates but not insulin resistance in lean and obese men. J Clin Invest 93:10-16, 1994
40. Poulin RA, Steil GM, Moore DM, et al: Dynamics of glucose production and uptake are more closely related to insulin in hindlimb lymph than in thoracic duct lymph. Diabetes 43:180-190, 1994
41. Roussel R, Velho G, Carlier PG, et al: In vivo NMR evidence for moderate glucose accumulation in human skeletal muscle during hyperglycemia. Am J Physiol 271:E434-E438, 1996
42. Shulman RG: Cellular mechanisms of insulin resistance in type 2 diabetes. ADEA/Australian Diabetes Society Scientific Meeting, Perth. Australia, August 27, 1998
43. 13C NMR method to assess intracellular glucose concentration in muscle, in vivo. Am J Physiol 274:E381-E389, 1998
44. Katz A, Nyomba BL, Bogardus C: No accumulation of glucose in human skeletal muscle during euglycemic hyperinsulinemia. Am J Physiol 255 E942-E945, 1988
45. Bonadonna RC, Del Prato S, Bonora E, et al: Roles of glucose transport and glucose phosphorylation in muscle insulin resistance of NIDDM. Diabetes 45:915-925, 1996
46. Eriksson J, Koranyi L, Bourey R, et al: Insulin resistance in type 2 (non-insulin-dependent) diabetic patients and their relatives is not associated with a defect in the expression of the insulin-responsive glucose transporter (GLUT-4) gene in human skeletal muscle. Diabetologia 35:143-147, 1992
47. Haber RS, Weinstein SP: Role of glucose transporters in glucocorticoid-induced insulin resistance. GLUT4 isoform in rat skeletal muscle is not decreased by dexamethasone. Diabetes 41:728-735, 1992